{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:31:04Z","timestamp":1786433464683,"version":"build-2736575974"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) is a malignancy with high global incidence and mortality, whose significant heterogeneity and poor prognosis pose severe clinical challenges. While artificial intelligence (AI) shows potential in HCC imaging, pathology, and prognosis, its \u201cblack-box\u201d nature limits clinical adoption. Explainable AI (XAI) aims to reveal the decision-making logic of AI models. This narrative review synthesizes recent advances of XAI across four key domains of HCC research. In imaging diagnosis, techniques such as Grad-CAM and SHAP have enabled semantic alignment between AI outputs and clinical standards like LI-RADS, enhancing interpretability. In biomarker discovery, XAI has progressed from identifying single markers to revealing functional gene modules and molecular subtypes through multi-omics integration. In treatment efficacy prediction, XAI-based models have quantified feature contributions to therapeutic responses, supporting individualized treatment stratification. In prognosis assessment, XAI has enabled dynamic risk stratification by integrating clinical, imaging, and pathological features. However, three cross-cutting limitations persist across these domains: explanations remain predominantly correlational rather than causal, a semantic gap exists between pixel-level heatmaps and high-level clinical reasoning, and most models are static, unable to adapt to evolving clinical data. Current research is moving toward causal inference frameworks, concept-driven interpretability, and interactive, dynamic systems. In summary, XAI is transitioning from a retrospective explanation tool toward a prospective clinical decision partner, yet bridging the gap between explanation and actionable decision support remains the central challenge.<\/jats:p>","DOI":"10.1186\/s43046-026-00397-0","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:04:28Z","timestamp":1786431868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From black-box prediction to transparent insight: the status quo and paradigm shift of explainable artificial intelligence in hepatocellular carcinoma research"],"prefix":"10.1186","volume":"38","author":[{"given":"Yuehua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"397_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"397_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif H, Ali MJ, Susheela AT, et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022;28:216\u201329. https:\/\/doi.org\/10.3748\/wjg.v28.i2.216.","journal-title":"World J Gastroenterol"},{"key":"397_CR3","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.4254\/wjh.v13.i12.2039","volume":"13","author":"JC Ahn","year":"2021","unstructured":"Ahn JC, Qureshi TA, Singal AG, et al. Deep learning in hepatocellular carcinoma: current status and future perspectives. World J Hepatol. 2021;13:2039\u201351. https:\/\/doi.org\/10.4254\/wjh.v13.i12.2039.","journal-title":"World J Hepatol"},{"key":"397_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21037\/tgh-20-242","volume":"7","author":"M Kawka","year":"2022","unstructured":"Kawka M, Dawidziuk A, Jiao LR, et al. Artificial intelligence in the detection, characterisation and prediction of hepatocellular carcinoma: a narrative review. Transl Gastroenterol Hepatol. 2022;7:41. https:\/\/doi.org\/10.21037\/tgh-20-242.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"397_CR5","doi-asserted-by":"publisher","first-page":"104600","DOI":"10.1016\/j.jbi.2024.104600","volume":"150","author":"JM Metsch","year":"2024","unstructured":"Metsch JM, Saranti A, Angerschmid A, et al. CLARUS: An interactive explainable AI platform for manual counterfactuals in graph neural networks. J Biomed Inf. 2024;150:104600. https:\/\/doi.org\/10.1016\/j.jbi.2024.104600.","journal-title":"J Biomed Inf"},{"key":"397_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.inffus.2021.07.016","volume":"77","author":"G Yang","year":"2022","unstructured":"Yang G, Ye Q, Xia J. Unbox the black-box for the medical explainable AI via multi-modal and multi-centre data fusion: a mini-review, two showcases and beyond. Inf Fusion. 2022;77:29\u201352. https:\/\/doi.org\/10.1016\/j.inffus.2021.07.016.","journal-title":"Inf Fusion"},{"key":"397_CR7","doi-asserted-by":"publisher","first-page":"29411","DOI":"10.1038\/s41598-025-14901-4","volume":"15","author":"A Rahman","year":"2025","unstructured":"Rahman A, Hayat M, Iqbal N, et al. Enhanced MRI brain tumor detection using deep learning in conjunction with explainable AI SHAP based diverse and multi feature analysis. Sci Rep. 2025;15:29411. https:\/\/doi.org\/10.1038\/s41598-025-14901-4.","journal-title":"Sci Rep"},{"key":"397_CR8","doi-asserted-by":"publisher","DOI":"10.1109\/jbhi.2025.3561024","author":"A Sharma","year":"2025","unstructured":"Sharma A, Varman U, Bharti V, et al. Cross-fusion of latent and attention features for explainable medical image classification. IEEE J Biomed Health Inf Pp. 2025. https:\/\/doi.org\/10.1109\/jbhi.2025.3561024.","journal-title":"IEEE J Biomed Health Inf Pp"},{"key":"397_CR9","doi-asserted-by":"publisher","first-page":"e240332","DOI":"10.1148\/rycan.240332","volume":"7","author":"M Li","year":"2025","unstructured":"Li M, Zhang Z, Chen Z, et al. Interactive explainable deep learning model for hepatocellular carcinoma diagnosis at gadoxetic acid-enhanced MRI: a retrospective, multicenter, diagnostic study. Radiol Imaging Cancer. 2025;7:e240332. https:\/\/doi.org\/10.1148\/rycan.240332.","journal-title":"Radiol Imaging Cancer"},{"key":"397_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/jmri.28056","volume":"56","author":"H Jiang","year":"2022","unstructured":"Jiang H, Song B, Qin Y, et al. Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: a secondary analysis of a prospective observational study. J Magn Reson Imaging. 2022;56:399\u2013412. https:\/\/doi.org\/10.1002\/jmri.28056.","journal-title":"J Magn Reson Imaging"},{"key":"397_CR11","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1038\/s41598-020-65875-4","volume":"10","author":"J Kim","year":"2020","unstructured":"Kim J, Min JH, Kim SK, et al. Detection of hepatocellular carcinoma in contrast-enhanced magnetic resonance imaging using deep learning classifier: a multi-center retrospective study. Sci Rep. 2020;10:9458. https:\/\/doi.org\/10.1038\/s41598-020-65875-4.","journal-title":"Sci Rep"},{"key":"397_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40644-021-00425-3","volume":"21","author":"SC Liu","year":"2021","unstructured":"Liu SC, Lai J, Huang JY, et al. Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals. Cancer Imaging. 2021;21:56. https:\/\/doi.org\/10.1186\/s40644-021-00425-3.","journal-title":"Cancer Imaging"},{"key":"397_CR13","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2147\/jhc.S515651","volume":"12","author":"L Guo","year":"2025","unstructured":"Guo L, Huang C, Hao P, et al. Can Peritumoral radiomics based on MRI predict the microvascular invasion status of combined hepatocellular carcinoma and cholangiocarcinoma before surgery? J Hepatocell Carcinoma. 2025;12:1441\u201352. https:\/\/doi.org\/10.2147\/jhc.S515651.","journal-title":"J Hepatocell Carcinoma"},{"key":"397_CR14","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.1016\/j.ejso.2024.108274","volume":"51","author":"S Famularo","year":"2025","unstructured":"Famularo S, Penzo C, Maino C, et al. Preoperative detection of hepatocellular carcinoma\u2019s microvascular invasion on CT-scan by machine learning and radiomics: A preliminary analysis. Eur J Surg Oncol. 2025;51:108274. https:\/\/doi.org\/10.1016\/j.ejso.2024.108274.","journal-title":"Eur J Surg Oncol"},{"key":"397_CR15","doi-asserted-by":"publisher","first-page":"1511260","DOI":"10.3389\/fonc.2025.1511260","volume":"15","author":"W Jian","year":"2025","unstructured":"Jian W, Zhan L, Zhaowang L, et al. Predicting microvascular invasion in solitary hepatocellular carcinoma: a multi-center study integrating clinical, MRI assessments, and radiomics indicators. Front Oncol. 2025;15:1511260. https:\/\/doi.org\/10.3389\/fonc.2025.1511260.","journal-title":"Front Oncol"},{"key":"397_CR16","doi-asserted-by":"publisher","first-page":"1566105","DOI":"10.3389\/fonc.2025.1566105","volume":"15","author":"H Fu","year":"2025","unstructured":"Fu H, Huang Y, Lu B, et al. Integrating intratumoral, peritumoral, and clinical features in an ultrasound-based radiomics model: contributions and synergies for predicting microvascular invasion in hepatocellular carcinoma. Front Oncol. 2025;15:1566105. https:\/\/doi.org\/10.3389\/fonc.2025.1566105.","journal-title":"Front Oncol"},{"key":"397_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-05266-3","author":"Z You","year":"2025","unstructured":"You Z, Wang Y, Zhou S. Integrated multi-task learning framework for hepatocellular carcinoma segmentation and histological grading using fused multi-phase MRI. Abdom Radiol (NY). 2025. https:\/\/doi.org\/10.1007\/s00261-025-05266-3.","journal-title":"Abdom Radiol (NY)"},{"key":"397_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12885-025-13978-4","volume":"25","author":"J Xu","year":"2025","unstructured":"Xu J, Li J, Wang T, et al. Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study. BMC Cancer. 2025;25:602. https:\/\/doi.org\/10.1186\/s12885-025-13978-4.","journal-title":"BMC Cancer"},{"key":"397_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2025.09.022","author":"X Shen","year":"2025","unstructured":"Shen X, Zhang JX, Yan HT, et al. CT-based habitat model for predicting tumor response and survival in hepatocellular carcinoma treated with transarterial chemoembolization combining molecular targeted agents and immune checkpoint inhibitors. Acad Radiol. 2025. https:\/\/doi.org\/10.1016\/j.acra.2025.09.022.","journal-title":"Acad Radiol"},{"key":"397_CR20","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","volume":"76","author":"J Calderaro","year":"2022","unstructured":"Calderaro J, Seraphin TP, Luedde T, et al. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J Hepatol. 2022;76:1348\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2022.01.014.","journal-title":"J Hepatol"},{"key":"397_CR21","doi-asserted-by":"publisher","first-page":"107646","DOI":"10.5306\/wjco.v16.i6.107646","volume":"16","author":"MH Peng","year":"2025","unstructured":"Peng MH, Zhang KL, Guan SW, et al. Advances and challenges in pathomics for liver cancer: from diagnosis to prognostic stratification. World J Clin Oncol. 2025;16:107646. https:\/\/doi.org\/10.5306\/wjco.v16.i6.107646.","journal-title":"World J Clin Oncol"},{"key":"397_CR22","doi-asserted-by":"publisher","first-page":"061407","DOI":"10.1117\/1.Jmi.12.6.061407","volume":"12","author":"G Takagi","year":"2025","unstructured":"Takagi G, Takeyama S, Abe T, et al. Quantification-based explainable artificial intelligence for deep learning decisions: clustering and visualization of quantitative morphometric features in hepatocellular carcinoma discrimination. J Med Imaging (Bellingham). 2025;12:061407. https:\/\/doi.org\/10.1117\/1.Jmi.12.6.061407.","journal-title":"J Med Imaging (Bellingham)"},{"key":"397_CR23","doi-asserted-by":"publisher","first-page":"103098","DOI":"10.1016\/j.eclinm.2025.103098","volume":"81","author":"Z Du","year":"2025","unstructured":"Du Z, Fan F, Ma J, et al. Development and validation of an ultrasound-based interpretable machine learning model for the classification of \u2264\u20093\u00a0cm hepatocellular carcinoma: a multicentre retrospective diagnostic study. EClinicalMedicine. 2025;81:103098. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103098.","journal-title":"EClinicalMedicine"},{"key":"397_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/embc40787.2023.10340750","volume":"2023","author":"J Liu","year":"2023","unstructured":"Liu J, Ma J, Ai Y, et al Vision-guided attention-enhanced network for predicting microvascular invasion in hepatocellular carcinoma. Annu Int Conf IEEE Eng Med Biol Soc. 2023;2023:1\u20134. https:\/\/doi.org\/10.1109\/embc40787.2023.10340750.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"397_CR25","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.ijrobp.2023.01.055","volume":"116","author":"I Chamseddine","year":"2023","unstructured":"Chamseddine I, Kim Y, De B, et al. Predictive model of liver toxicity to aid the personalized selection of proton versus photon therapy in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2023;116:1234\u201343. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.01.055.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"397_CR26","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1038\/s41467-025-64292-3","volume":"16","author":"P Ren","year":"2025","unstructured":"Ren P, Zhang R, Wang Y, et al. Systematic benchmarking of high-throughput subcellular spatial transcriptomics platforms across human tumors. Nat Commun. 2025;16:9232. https:\/\/doi.org\/10.1038\/s41467-025-64292-3.","journal-title":"Nat Commun"},{"key":"397_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000542099","volume":"14","author":"E Ueshima","year":"2025","unstructured":"Ueshima E, Sofue K, Kodama T, et al. Gadoxetic acid-enhanced magnetic resonance imaging features can predict immune-excluded phenotype of hepatocellular carcinoma. Liver Cancer. 2025;14:271\u201385. https:\/\/doi.org\/10.1159\/000542099.","journal-title":"Liver Cancer"},{"key":"397_CR28","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1016\/j.acra.2025.07.018","volume":"32","author":"W Zou","year":"2025","unstructured":"Zou W, Gu M, Chen H, et al. Radiomics with machine learning improves the prediction of microscopic peritumoral small cancer foci and early recurrence in hepatocellular carcinoma. Acad Radiol. 2025;32:5774\u201388. https:\/\/doi.org\/10.1016\/j.acra.2025.07.018.","journal-title":"Acad Radiol"},{"key":"397_CR29","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s12072-025-10793-8","volume":"19","author":"A Liu","year":"2025","unstructured":"Liu A, Zhang J, Li T, et al. Explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in hepatocellular carcinoma. Hepatol Int. 2025;19:866\u201376. https:\/\/doi.org\/10.1007\/s12072-025-10793-8.","journal-title":"Hepatol Int"},{"key":"397_CR30","doi-asserted-by":"publisher","unstructured":"Gutierrez-Chakraborty E, Chakraborty D, Das D, et al. Discovering novel prognostic biomarkers of hepatocellular carcinoma using eXplainable Artificial Intelligence. Expert Syst Appl. 2024;252. https:\/\/doi.org\/10.1016\/j.eswa.2024.124239.","DOI":"10.1016\/j.eswa.2024.124239"},{"key":"397_CR31","doi-asserted-by":"publisher","unstructured":"Yagin FH, Shawi E, Algarni R. Metabolomics Biomarker Discovery to Optimize Hepatocellular Carcinoma Diagnosis: Methodology Integrating AutoML and Explainable Artificial Intelligence. Diagnostics (Basel). 2024;14. https:\/\/doi.org\/10.3390\/diagnostics14182049.","DOI":"10.3390\/diagnostics14182049"},{"key":"397_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12920-021-00957-4","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Liu ZP. Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods. BMC Med Genomics. 2021;14:112. https:\/\/doi.org\/10.1186\/s12920-021-00957-4.","journal-title":"BMC Med Genomics"},{"key":"397_CR33","doi-asserted-by":"publisher","unstructured":"Lacalamita A, Serino G, Pantaleo E, et al. Artificial intelligence and complex network approaches reveal potential gene biomarkers for hepatocellular carcinoma. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms242015286.","DOI":"10.3390\/ijms242015286"},{"key":"397_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12859-021-04454-4","volume":"22","author":"AR Owens","year":"2021","unstructured":"Owens AR, McInerney CE, Prise KM, et al. Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma). BMC Bioinformatics. 2021;22:563. https:\/\/doi.org\/10.1186\/s12859-021-04454-4.","journal-title":"BMC Bioinformatics"},{"key":"397_CR35","doi-asserted-by":"publisher","unstructured":"Wang R, Liu Q, You W, et al. A transformer-based deep learning survival prediction model and an explainable XGBoost anti-PD-1\/PD-L1 outcome prediction model based on the cGAS-STING-centered pathways in hepatocellular carcinoma. Brief Bioinform. 2024;26. https:\/\/doi.org\/10.1093\/bib\/bbae686.","DOI":"10.1093\/bib\/bbae686"},{"key":"397_CR36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s12072-022-10323-w","volume":"16","author":"Q Chen","year":"2022","unstructured":"Chen Q, Xiao H, Gu Y, et al. Deep learning for evaluation of microvascular invasion in hepatocellular carcinoma from tumor areas of histology images. Hepatol Int. 2022;16:590\u2013602. https:\/\/doi.org\/10.1007\/s12072-022-10323-w.","journal-title":"Hepatol Int"},{"key":"397_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-337945","author":"HY Huang","year":"2026","unstructured":"Huang HY, Wu K, Qu LM, et al. Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio. Gut. 2026. https:\/\/doi.org\/10.1136\/gutjnl-2025-337945.","journal-title":"Gut"},{"key":"397_CR38","doi-asserted-by":"publisher","unstructured":"Zhang H, Liu M, Zhao X, et al. DuXplore: a dual-hierarchical deep learning model for prognostic prediction of hepatocellular carcinoma in digital pathology. Diagnostics (Basel). 2025;15. https:\/\/doi.org\/10.3390\/diagnostics15232981.","DOI":"10.3390\/diagnostics15232981"},{"key":"397_CR39","doi-asserted-by":"publisher","first-page":"lqab015","DOI":"10.1093\/nargab\/lqab015","volume":"3","author":"Z Zhan","year":"2021","unstructured":"Zhan Z, Jing Z, He B, et al. Two-stage Cox-nnet: biologically interpretable neural-network model for prognosis prediction and its application in liver cancer survival using histopathology and transcriptomic data. NAR Genom Bioinform. 2021;3:lqab015. https:\/\/doi.org\/10.1093\/nargab\/lqab015.","journal-title":"NAR Genom Bioinform"},{"key":"397_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/a-2299-7880","volume":"44","author":"N Fujiwara","year":"2024","unstructured":"Fujiwara N, Kimura G, Nakagawa H. Emerging roles of spatial transcriptomics in liver research. Semin Liver Dis. 2024;44:115\u201332. https:\/\/doi.org\/10.1055\/a-2299-7880.","journal-title":"Semin Liver Dis"},{"key":"397_CR41","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten TF, Villanueva A, Korangy F, et al. Biomarkers for immunotherapy of hepatocellular carcinoma. Nat Rev Clin Oncol. 2023;20:780\u201398. https:\/\/doi.org\/10.1038\/s41571-023-00816-4.","journal-title":"Nat Rev Clin Oncol"},{"key":"397_CR42","doi-asserted-by":"publisher","unstructured":"Cheu JW, Wong CC. The immune microenvironment of steatotic hepatocellular carcinoma: current findings and future prospects. Hepatol Commun. 2024;8. https:\/\/doi.org\/10.1097\/hc9.0000000000000516.","DOI":"10.1097\/hc9.0000000000000516"},{"key":"397_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-025-01668-3","author":"Y Gao","year":"2025","unstructured":"Gao Y, Miao Y, Cai H, et al. Noninvasive multi-omics radiomic model integrating scRNA-seq and Bulk RNA-seq for hepatocellular carcinoma prognosis. J Imaging Inf Med. 2025. https:\/\/doi.org\/10.1007\/s10278-025-01668-3.","journal-title":"J Imaging Inf Med"},{"key":"397_CR44","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.21037\/tcr-24-1155","volume":"14","author":"Z Xu","year":"2025","unstructured":"Xu Z, Huang W, Zou X, et al. Integrated machine learning constructed a circadian-rhythm-related model to assess clinical outcomes and therapeutic advantages in hepatocellular carcinoma. Transl Cancer Res. 2025;14:1799\u2013823. https:\/\/doi.org\/10.21037\/tcr-24-1155.","journal-title":"Transl Cancer Res"},{"key":"397_CR45","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s12672-025-03254-z","volume":"16","author":"W Ding","year":"2025","unstructured":"Ding W, Zhang J, Jin Z, et al. Artificial intelligence-driven pathomics in hepatocellular carcinoma: current developments, challenges and perspectives. Discov Oncol. 2025;16:1424. https:\/\/doi.org\/10.1007\/s12672-025-03254-z.","journal-title":"Discov Oncol"},{"key":"397_CR46","doi-asserted-by":"publisher","first-page":"107042","DOI":"10.1016\/j.crad.2025.107042","volume":"89","author":"K Sweta","year":"2025","unstructured":"Sweta K, Dkhar W, Kadavigere R, et al. Diagnostic accuracy of computed tomography (CT)-based radiomics and artificial intelligence (AI) models in hepatocellular carcinoma: a systematic review and meta-analysis. Clin Radiol. 2025;89:107042. https:\/\/doi.org\/10.1016\/j.crad.2025.107042.","journal-title":"Clin Radiol"},{"key":"397_CR47","doi-asserted-by":"publisher","first-page":"1008855","DOI":"10.3389\/fmed.2022.1008855","volume":"9","author":"JM Lee","year":"2022","unstructured":"Lee JM, Hung YP, Chou KY, et al. Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma. Front Med (Lausanne). 2022;9:1008855. https:\/\/doi.org\/10.3389\/fmed.2022.1008855.","journal-title":"Front Med (Lausanne)"},{"key":"397_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12876-025-04105-5","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Tong S, Yang J, et al. Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients. BMC Gastroenterol. 2025;25:503. https:\/\/doi.org\/10.1186\/s12876-025-04105-5.","journal-title":"BMC Gastroenterol"},{"key":"397_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11547-024-01785-z","volume":"129","author":"L Zhang","year":"2024","unstructured":"Zhang L, Jin Z, Li C, et al. An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma. Radiol Med. 2024;129:353\u201367. https:\/\/doi.org\/10.1007\/s11547-024-01785-z.","journal-title":"Radiol Med"},{"key":"397_CR50","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.hbpd.2022.11.005","volume":"22","author":"DD Wang","year":"2023","unstructured":"Wang DD, Zhang JF, Zhang LH, et al. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study. Hepatobiliary Pancreat Dis Int. 2023;22:594\u2013604. https:\/\/doi.org\/10.1016\/j.hbpd.2022.11.005.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"397_CR51","doi-asserted-by":"publisher","first-page":"14779","DOI":"10.1038\/s41598-024-65630-z","volume":"14","author":"K Bartnik","year":"2024","unstructured":"Bartnik K, Krzyzi\u0144ski M, Bartczak T, et al. A novel radiomics approach for predicting TACE outcomes in hepatocellular carcinoma patients using deep learning for multi-organ segmentation. Sci Rep. 2024;14:14779. https:\/\/doi.org\/10.1038\/s41598-024-65630-z.","journal-title":"Sci Rep"},{"key":"397_CR52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2147\/jhc.S503581","volume":"12","author":"J Li","year":"2025","unstructured":"Li J, Feng T, Cui C, et al. Post-TACE ALBI-score trajectory in intermediate and advanced hepatocellular carcinoma: prognostic implications and influencing factors analysis. J Hepatocell Carcinoma. 2025;12:865\u201378. https:\/\/doi.org\/10.2147\/jhc.S503581.","journal-title":"J Hepatocell Carcinoma"},{"key":"397_CR53","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2147\/jhc.S513696","volume":"12","author":"D Lu","year":"2025","unstructured":"Lu D, Zhou L, Zuo Z, et al. MRI radiomics to predict early treatment response to TACE combined with Lenvatinib Plus a PD-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus. J Hepatocell Carcinoma. 2025;12:985\u201398. https:\/\/doi.org\/10.2147\/jhc.S513696.","journal-title":"J Hepatocell Carcinoma"},{"key":"397_CR54","doi-asserted-by":"publisher","first-page":"112353","DOI":"10.1016\/j.ejrad.2025.112353","volume":"191","author":"R Huang","year":"2025","unstructured":"Huang R, Liu K, Yan L, et al. Development and validation of interpretable machine learning model for pre-treatment predicting the response to targeted and immune therapy in hepatocellular carcinoma. Eur J Radiol. 2025;191:112353. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112353.","journal-title":"Eur J Radiol"},{"key":"397_CR55","doi-asserted-by":"publisher","unstructured":"Ma J, Bo Z, Zhao Z, et al. Machine learning to predict the response to lenvatinib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15030625.","DOI":"10.3390\/cancers15030625"},{"key":"397_CR56","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1038\/s41598-024-57078-y","volume":"14","author":"Y Nakao","year":"2024","unstructured":"Nakao Y, Nishihara T, Sasaki R, et al. Investigation of deep learning model for predicting immune checkpoint inhibitor treatment efficacy on contrast-enhanced computed tomography images of hepatocellular carcinoma. Sci Rep. 2024;14:6576. https:\/\/doi.org\/10.1038\/s41598-024-57078-y.","journal-title":"Sci Rep"},{"key":"397_CR57","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.7150\/jca.111026","volume":"16","author":"J Chen","year":"2025","unstructured":"Chen J, Chen J, Ye Y, et al. Pretreatment multi-sequence contrast-enhanced MRI to predict response to immunotherapy in unresectable hepatocellular carcinoma using transformer: a multicenter study. J Cancer. 2025;16:2663\u201372. https:\/\/doi.org\/10.7150\/jca.111026.","journal-title":"J Cancer"},{"key":"397_CR58","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2147\/jhc.S523448","volume":"12","author":"F Liu","year":"2025","unstructured":"Liu F, Chen L, Wu Q, et al. Radiomics of dynamic contrast-enhanced MRI for predicting radiation-induced hepatic toxicity after intensity modulated radiotherapy for hepatocellular carcinoma: a machine learning predictive model based on the SHAP methodology. J Hepatocell Carcinoma. 2025;12:999\u20131015. https:\/\/doi.org\/10.2147\/jhc.S523448.","journal-title":"J Hepatocell Carcinoma"},{"key":"397_CR59","doi-asserted-by":"publisher","unstructured":"Tabari A, D\u2019Amore B, Cox M, et al. Machine learning-based radiomic features on Pre-ablation MRI as predictors of pathologic response in patients with hepatocellular carcinoma who underwent hepatic transplant. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15072058.","DOI":"10.3390\/cancers15072058"},{"key":"397_CR60","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2147\/jhc.S358197","volume":"9","author":"C An","year":"2022","unstructured":"An C, Yang H, Yu X, et al. A machine learning model based on health records for predicting recurrence after microwave ablation of hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;9:671\u201384. https:\/\/doi.org\/10.2147\/jhc.S358197.","journal-title":"J Hepatocell Carcinoma"},{"key":"397_CR61","doi-asserted-by":"publisher","first-page":"e3732","DOI":"10.1002\/jgm.3732","volume":"26","author":"J Sun","year":"2024","unstructured":"Sun J, Huang L, Liu Y. Leveraging SEER data through machine learning to predict distant lymph node metastasis and prognosticate outcomes in hepatocellular carcinoma patients. J Gene Med. 2024;26:e3732. https:\/\/doi.org\/10.1002\/jgm.3732.","journal-title":"J Gene Med"},{"key":"397_CR62","doi-asserted-by":"publisher","first-page":"e2400108","DOI":"10.1200\/cci.24.00108","volume":"8","author":"H Nakahara","year":"2024","unstructured":"Nakahara H, Ono A, Hayes CN, et al. Prediction of hepatocellular carcinoma after Hepatitis C virus sustained virologic response using a random survival forest model. JCO Clin Cancer Inf. 2024;8:e2400108. https:\/\/doi.org\/10.1200\/cci.24.00108.","journal-title":"JCO Clin Cancer Inf"},{"key":"397_CR63","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41746-025-02100-4","volume":"8","author":"F Cao","year":"2025","unstructured":"Cao F, An C, Li S, et al. Deep learning model for assessing survival benefits in hepatocellular carcinoma patients undergoing intra-arterial therapies based on proliferative subtype. NPJ Digit Med. 2025;8:692. https:\/\/doi.org\/10.1038\/s41746-025-02100-4.","journal-title":"NPJ Digit Med"},{"key":"397_CR64","doi-asserted-by":"publisher","first-page":"e22458","DOI":"10.1016\/j.heliyon.2023.e22458","volume":"9","author":"R Liu","year":"2023","unstructured":"Liu R, Wu S, Yu HY, et al. Prediction model for hepatocellular carcinoma recurrence after hepatectomy: machine learning-based development and interpretation study. Heliyon. 2023;9:e22458. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22458.","journal-title":"Heliyon"},{"key":"397_CR65","doi-asserted-by":"publisher","first-page":"116716","DOI":"10.1016\/j.amjsurg.2025.116716","volume":"251","author":"ZC Yu","year":"2025","unstructured":"Yu ZC, Shi ZJ, Fang ZK, et al. Development and validation of machine learning-based model for predicting early recurrence for patients with HBV-associated hepatocellular carcinoma after curative hepatectomy. Am J Surg. 2025;251:116716. https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116716.","journal-title":"Am J Surg"},{"key":"397_CR66","doi-asserted-by":"publisher","first-page":"e44966","DOI":"10.1097\/md.0000000000044966","volume":"104","author":"J Wang","year":"2025","unstructured":"Wang J, Shen T, Wang S. Construction of a prediction model for hepatocellular carcinoma based on machine learning and its prognostic characteristics. Med (Baltim). 2025;104:e44966. https:\/\/doi.org\/10.1097\/md.0000000000044966.","journal-title":"Med (Baltim)"},{"key":"397_CR67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.hpb.2024.12.015","volume":"27","author":"A Altaf","year":"2025","unstructured":"Altaf A, Munir MM, Khan MMM, et al. Machine learning based prediction model for bile leak following hepatectomy for liver cancer. HPB (Oxford). 2025;27:489\u2013501. https:\/\/doi.org\/10.1016\/j.hpb.2024.12.015.","journal-title":"HPB (Oxford)"},{"key":"397_CR68","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1186\/s12885-024-13366-4","volume":"24","author":"J Zhang","year":"2024","unstructured":"Zhang J, Chen Q, Zhang Y, et al. Construction of a random survival forest model based on a machine learning algorithm to predict early recurrence after hepatectomy for adult hepatocellular carcinoma. BMC Cancer. 2024;24:1575. https:\/\/doi.org\/10.1186\/s12885-024-13366-4.","journal-title":"BMC Cancer"},{"key":"397_CR69","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1016\/j.acra.2025.04.018","volume":"32","author":"Y Qin","year":"2025","unstructured":"Qin Y, Zhang LG, Zhou X, et al. Explainable fusion model for predicting postoperative early recurrence in hepatocellular carcinoma using gadoxetic acid-enhanced MRI habitat imaging. Acad Radiol. 2025;32:5162\u201372. https:\/\/doi.org\/10.1016\/j.acra.2025.04.018.","journal-title":"Acad Radiol"},{"key":"397_CR70","doi-asserted-by":"publisher","first-page":"1589884","DOI":"10.3389\/fonc.2025.1589884","volume":"15","author":"Y Wei","year":"2025","unstructured":"Wei Y, Qian G, Meng T, et al. Changes in perioperative serum transaminase levels: predicting early recurrence after hepatectomy for hepatocellular carcinoma. Front Oncol. 2025;15:1589884. https:\/\/doi.org\/10.3389\/fonc.2025.1589884.","journal-title":"Front Oncol"},{"key":"397_CR71","doi-asserted-by":"publisher","unstructured":"Wang C, Ding Q, Liu M, et al. Machine learning-based models for the prediction of postoperative recurrence risk in MVI-negative HCC. Biomedicines. 2025;13. https:\/\/doi.org\/10.3390\/biomedicines13102507.","DOI":"10.3390\/biomedicines13102507"},{"key":"397_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.06.031","author":"J Peng","year":"2025","unstructured":"Peng J, Wang J, Zhu H, et al. Three-dimensional multimodal imaging for predicting early recurrence of hepatocellular carcinoma after surgical resection. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.06.031.","journal-title":"J Adv Res"},{"key":"397_CR73","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12094-024-03588-0","volume":"27","author":"H Li","year":"2025","unstructured":"Li H, Zhou C, Wang C, et al. Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma. Clin Transl Oncol. 2025;27:309\u201318. https:\/\/doi.org\/10.1007\/s12094-024-03588-0.","journal-title":"Clin Transl Oncol"},{"key":"397_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/jhc.S496481","volume":"12","author":"L Wu","year":"2025","unstructured":"Wu L, Chen L, Zhang L, et al. A machine learning model for predicting prognosis in HCC patients with diabetes after TACE. J Hepatocell Carcinoma. 2025;12:77\u201391. https:\/\/doi.org\/10.2147\/jhc.S496481.","journal-title":"J Hepatocell Carcinoma"},{"key":"397_CR75","doi-asserted-by":"publisher","first-page":"1640075","DOI":"10.3389\/fimmu.2025.1640075","volume":"16","author":"TX Yang","year":"2025","unstructured":"Yang TX, Su JY, Li MJ, et al. Development of a machine learning model to predict overall survival for large hepatocellular carcinoma at BCLC stage A or B after curative hepatectomy. Front Immunol. 2025;16:1640075. https:\/\/doi.org\/10.3389\/fimmu.2025.1640075.","journal-title":"Front Immunol"},{"key":"397_CR76","doi-asserted-by":"publisher","first-page":"20557","DOI":"10.1038\/s41598-025-06198-0","volume":"15","author":"J Chen","year":"2025","unstructured":"Chen J, Lei Z, Duan Z, et al. Modeling the prediction of spontaneous rupture and bleeding in hepatocellular carcinoma via machine learning algorithms. Sci Rep. 2025;15:20557. https:\/\/doi.org\/10.1038\/s41598-025-06198-0.","journal-title":"Sci Rep"},{"key":"397_CR77","doi-asserted-by":"publisher","first-page":"15469","DOI":"10.1038\/s41598-025-97878-4","volume":"15","author":"T Tang","year":"2025","unstructured":"Tang T, Guo T, Zhu B, et al. Interpretable machine learning model for predicting post-hepatectomy liver failure in hepatocellular carcinoma. Sci Rep. 2025;15:15469. https:\/\/doi.org\/10.1038\/s41598-025-97878-4.","journal-title":"Sci Rep"},{"key":"397_CR78","doi-asserted-by":"publisher","unstructured":"Zhong X, Salahuddin Z, Chen Y, et al. An interpretable radiomics model based on two-dimensional shear wave elastography for predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15215303.","DOI":"10.3390\/cancers15215303"},{"key":"397_CR79","doi-asserted-by":"publisher","first-page":"1452201","DOI":"10.3389\/fphar.2024.1452201","volume":"15","author":"H Li","year":"2024","unstructured":"Li H, Yang B, Wang C, et al. Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (\u2265\u20095\u00a0cm) using lasso-cox regression. Front Pharmacol. 2024;15:1452201. https:\/\/doi.org\/10.3389\/fphar.2024.1452201.","journal-title":"Front Pharmacol"},{"key":"397_CR80","doi-asserted-by":"publisher","first-page":"146045822413047","DOI":"10.1177\/14604582241304730","volume":"30","author":"A Brankovic","year":"2024","unstructured":"Brankovic A, Cook D, Rahman J, et al. Benchmarking the most popular XAI used for explaining clinical predictive models: Untrustworthy but could be useful. Health Inf J. 2024;30:14604582241304730. https:\/\/doi.org\/10.1177\/14604582241304730.","journal-title":"Health Inf J"},{"key":"397_CR81","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1109\/tnnls.2020.3027314","volume":"32","author":"E Tjoa","year":"2021","unstructured":"Tjoa E, Guan CA. Survey on explainable artificial intelligence (XAI): toward medical XAI. IEEE Trans Neural Netw Learn Syst. 2021;32:4793\u2013813. https:\/\/doi.org\/10.1109\/tnnls.2020.3027314.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"key":"397_CR82","doi-asserted-by":"publisher","first-page":"105689","DOI":"10.1016\/j.ijmedinf.2024.105689","volume":"193","author":"Y Abas Mohamed","year":"2025","unstructured":"Abas Mohamed Y, Ee Khoo B, Shahrimie Mohd Asaari M, et al. Decoding the black box: Explainable AI (XAI) for cancer diagnosis, prognosis, and treatment planning-A state-of-the art systematic review. Int J Med Inf. 2025;193:105689. https:\/\/doi.org\/10.1016\/j.ijmedinf.2024.105689.","journal-title":"Int J Med Inf"},{"key":"397_CR83","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41591-024-02902-1","volume":"30","author":"S Feuerriegel","year":"2024","unstructured":"Feuerriegel S, Frauen D, Melnychuk V, et al. Causal machine learning for predicting treatment outcomes. Nat Med. 2024;30:958\u201368. https:\/\/doi.org\/10.1038\/s41591-024-02902-1.","journal-title":"Nat Med"},{"key":"397_CR84","doi-asserted-by":"publisher","first-page":"220638","DOI":"10.1098\/rsos.220638","volume":"9","author":"P Sanchez","year":"2022","unstructured":"Sanchez P, Voisey JP, Xia T, et al. Causal machine learning for healthcare and precision medicine. R Soc Open Sci. 2022;9:220638. https:\/\/doi.org\/10.1098\/rsos.220638.","journal-title":"R Soc Open Sci"},{"key":"397_CR85","doi-asserted-by":"publisher","unstructured":"Li W, Wang B, Li T, et al. A causal and interpretable machine learning framework for postcranioplasty risk prediction and surgical decision support. NPJ Digit Med. 2026;9. https:\/\/doi.org\/10.1038\/s41746-026-02370-6.","DOI":"10.1038\/s41746-026-02370-6"},{"key":"397_CR86","doi-asserted-by":"publisher","first-page":"1574797","DOI":"10.3389\/fbinf.2025.1574797","volume":"5","author":"YC Wang","year":"2025","unstructured":"Wang YC, Bulte D, Brady M. Bridging the gap between hepatocellular carcinoma management guidelines and personalised medicine: a Bayesian network study. Front Bioinform. 2025;5:1574797. https:\/\/doi.org\/10.3389\/fbinf.2025.1574797.","journal-title":"Front Bioinform"},{"key":"397_CR87","doi-asserted-by":"publisher","first-page":"101565","DOI":"10.1016\/j.jhepr.2025.101565","volume":"7","author":"XP Meng","year":"2025","unstructured":"Meng XP, Chen FM, Tang TY, et al. Anatomical resection is associated with reduced early recurrences in HCC: A machine learning analysis. JHEP Rep. 2025;7:101565. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101565.","journal-title":"JHEP Rep"},{"key":"397_CR88","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1109\/tpami.2024.3489597","volume":"47","author":"R Zhang","year":"2025","unstructured":"Zhang R, Du X, Yan J, et al. The decoupling concept bottleneck model. IEEE Trans Pattern Anal Mach Intell. 2025;47:1250\u201365. https:\/\/doi.org\/10.1109\/tpami.2024.3489597.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"397_CR89","unstructured":"Nm, L, C, S, N, P, et al Evaluating the Utility of Sparse Autoencoders for Interpreting a Pathology Foundation Model. 39th Conference on Neural Information Processing Systems. 2025. https:\/\/neurips.cc\/virtual\/2025\/loc\/san-diego\/128786."},{"key":"397_CR90","doi-asserted-by":"publisher","first-page":"103730","DOI":"10.1016\/j.media.2025.103730","volume":"106","author":"P Kumari","year":"2025","unstructured":"Kumari P, Chauhan J, Bozorgpour A, et al. Continual learning in medical image analysis: A comprehensive review of recent advancements and future prospects. Med Image Anal. 2025;106:103730. https:\/\/doi.org\/10.1016\/j.media.2025.103730.","journal-title":"Med Image Anal"},{"key":"397_CR91","doi-asserted-by":"publisher","unstructured":"Goethals S, Martens D, Calders T. PreCoF: counterfactual explanations for fairness. Mach Learn. 2023;1\u201332. https:\/\/doi.org\/10.1007\/s10994-023-06319-8.","DOI":"10.1007\/s10994-023-06319-8"},{"key":"397_CR92","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00261-025-05059-8","volume":"51","author":"M Hori","year":"2026","unstructured":"Hori M, Suzuki Y, Sofue K, et al. Artificial intelligence in imaging diagnosis of liver tumors: current status and future prospects. Abdom Radiol (NY). 2026;51:446\u201357. https:\/\/doi.org\/10.1007\/s00261-025-05059-8.","journal-title":"Abdom Radiol (NY)"},{"key":"397_CR93","doi-asserted-by":"publisher","first-page":"111176","DOI":"10.3748\/wjg.v31.i46.111176","volume":"31","author":"JR Sun","year":"2025","unstructured":"Sun JR, Sun XN, Lu BJ, et al. Artificial intelligence in hepatopathy diagnosis and treatment: big data analytics, deep learning, and clinical prediction models. World J Gastroenterol. 2025;31:111176. https:\/\/doi.org\/10.3748\/wjg.v31.i46.111176.","journal-title":"World J Gastroenterol"},{"key":"397_CR94","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/13696998.2025.2525006","volume":"28","author":"L Maas","year":"2025","unstructured":"Maas L, Contreras-Meca C, Ghezzo S, et al. Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy. J Med Econ. 2025;28:1023\u201336. https:\/\/doi.org\/10.1080\/13696998.2025.2525006.","journal-title":"J Med Econ"},{"key":"397_CR95","doi-asserted-by":"publisher","unstructured":"Wongsuwan J, Tubtawee T, Nirattisaikul S, et al. Enhancing ultrasonographic detection of hepatocellular carcinoma with artificial intelligence: current applications, challenges and future directions. BMJ Open Gastroenterol. 2025;12. https:\/\/doi.org\/10.1136\/bmjgast-2025-001832.","DOI":"10.1136\/bmjgast-2025-001832"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00397-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:04:30Z","timestamp":1786431870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00397-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00397-0","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}